Efficacy and Safety of Trastuzumab Emtansine in Chinese Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer
type: MedicalStudy
description: A Randomized, Multicenter, Phase III Open-Label Study of the Efficacy and Safety of Trastuzumab Emtansine Versus Lapatinib Plus Capecitabine in Chinese Patients With HER2-Positive Locally Advanced or Metastatic Breast Cancer Who Have Received Prior Trastuzumab-Based Therapy
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE3
start date: 2017-04-24
end date: 2023-03-14
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT03084939
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Hoffmann-La Roche
study subject: Breast Cancer
keywords: PHASE3
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Breast Cancer

AI Analytics
type: Organization